Literature DB >> 11162784

3,3'-diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout.

A D Shilling1, D B Carlson, S Katchamart, D E Williams.   

Abstract

Indole-3-carbinol (I3C), a compound found in Brassica vegetables has been widely studied for its chemopreventive properties. I3C has been shown to block tumor initiation and promotion; however, it also acts as a tumor promoter. I3C and some of its acid condensation products, particularly 3,3'-diindolylmethane (I33'), have exhibited antiestrogenic properties. We report that I33' acts as an estrogen in the rainbow trout liver in vitro and in vivo by inducing vitellogenin (Vg), a well-characterized biomarker for estrogens. Precision-cut liver slices from male rainbow trout, Oncorhynchus mykiss, were incubated at 14 degrees C for 96 h in media containing I3C, I33', or a mixture of I3C acid condensation products (RXN) (0-250 microM). I33' and RXN increased Vg levels in rainbow trout liver slices by over 300- and 20-fold, respectively, vs vehicle. The efficacy of I33' induction of Vg was comparable to 17 beta-estradiol (E(2)) with 2500-fold less potency. I33' and E(2) cotreatment resulted in additive Vg induction. Tamoxifen completely inhibited I33'-induced Vg induction, suggesting that Vg induction by I33' is entirely through the estrogen receptor. In vivo, juvenile male rainbow trout were fed I3C, RXN (0-2000 mg/kg), or I33' (0-250 mg/kg) for 2 weeks. At 2000 mg/kg, I3C induced Vg by over 100,000-fold compared to controls, which was comparable to 5 mg/kg 17 beta-estradiol (the dose resulting in maximum induction). I33' was five times as potent as I3C with equal efficacy. The potency of RXN was only 5% of I3C. Again, I33' and E(2) cotreatment resulted in additive Vg induction. I33' may have accounted for Vg increases observed in trout fed I3C as it is present in liver after oral dosing at concentrations (70 microM) expected to maximally induce Vg. In trout, results in vitro and in vivo document that I33' is estrogenic, consistent with our hypothesis that I3C promotes liver cancer in trout by estrogenic pathways. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162784     DOI: 10.1006/taap.2000.9100

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

Review 1.  Targeting NR4A1 (TR3) in cancer cells and tumors.

Authors:  Syng-Ook Lee; Xi Li; Shaheen Khan; Stephen Safe
Journal:  Expert Opin Ther Targets       Date:  2011-01-05       Impact factor: 6.902

Review 2.  The rainbow trout liver cancer model: response to environmental chemicals and studies on promotion and chemoprevention.

Authors:  David E Williams
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-06-16       Impact factor: 3.228

Review 3.  Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis.

Authors:  Jane V Higdon; Barbara Delage; David E Williams; Roderick H Dashwood
Journal:  Pharmacol Res       Date:  2007-01-25       Impact factor: 7.658

4.  Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer.

Authors:  Shadan Ali; Sanjeev Banerjee; Aamir Ahmad; Bassel F El-Rayes; Philip A Philip; Fazlul H Sarkar
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

5.  Identification of a transcriptional fingerprint of estrogen exposure in rainbow trout liver.

Authors:  Abby D Benninghoff; David E Williams
Journal:  Toxicol Sci       Date:  2007-09-06       Impact factor: 4.849

6.  The role of estrogen receptor β in transplacental cancer prevention by indole-3-carbinol.

Authors:  Abby D Benninghoff; David E Williams
Journal:  Cancer Prev Res (Phila)       Date:  2013-02-27

Review 7.  Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.

Authors:  Stephen Safe; Sabitha Papineni; Sudhakar Chintharlapalli
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

8.  3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans.

Authors:  Monica L Vermillion Maier; Lisbeth K Siddens; Sandra L Uesugi; Jaewoo Choi; Scott W Leonard; Jamie M Pennington; Susan C Tilton; Jordan N Smith; Emily Ho; H H Sherry Chow; Bach D Nguyen; Siva K Kolluri; David E Williams
Journal:  Drug Metab Dispos       Date:  2021-05-25       Impact factor: 3.579

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.